Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-1110 in Major Depressive Disorder
NCT06792136Phase 2Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Jan 2025
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ONO-1110 in major depressive disorder (MDD), sponsored by Ono Pharmaceutical. Started Jan 2025; status: completed.
02
Drugs
ONO-1110
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06792136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06792136.